Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been recently diagnosed with Acute Myeloid Leukemia (a type of blood cancer) and are being treated with a specific combination of drugs called HMA-VEN
- Your cancer has gone into remission (meaning treatment is working and signs of the cancer have reduced), and you are starting from your first treatment cycle after remission
Who may not be able to join:
- You are currently taking certain medications that strongly or moderately affect how the body breaks down drugs (known as CYP3A4 inhibitors or inducers — confirm with trial site if you are unsure whether your medications fall into this category)
- You are not willing to follow the treatment plan as required by the trial, or you are not willing to have your blood tested to measure drug levels at the specific times set out by the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390382503070
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Analysis of the association between VEN plasma levels and the incidence of grade IV neutropenia.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.